Bangalore-based biotechnology major Biocon Ltd has signed a memorandum of understanding with Australia's Deakin University. |
Following the tie-up, Deakin University will set up the Deakin Research Institute in Bangalore. The two will also jointly develop a mammalian cell bio-processing facility in Australia. Deakin, through its metabolic research unit, will undertake research on metabolic diseases on behalf of Biocon. |
"The signing of this MOU will formally initiate collaboration in research and education between Biocon and Deakin University. This partnership will provide valuable access to medical knowledge and scientific training, together with opportunities for exchange of scientists to facilitate projects in areas of mutual interest" Kiran Mazumdar-Shaw, CMD of Biocon said. |
"It is a significant move for Deakin University, providing links with an international company in key areas of research interest including biotechnology, metabolic disease research and wine science," said Professor Sally Walker from Deakin University. |